Opko Health Inc. (NYSE:OPK) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report issued on Wednesday. According to Zacks, “OPKO Health is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development and commercialization expertise […]
